Status:
UNKNOWN
Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood
Lead Sponsor:
University Hospital Freiburg
Conditions:
Myelodysplastic Syndromes
Juvenile Myelomonocytic Leukemia
Eligibility:
All Genders
Up to 215 years
Brief Summary
The aim of the study is to improve the accuracy of diagnosis for children and adolescents with MDS by a standardized review of morphology and standardized cytogenetic and molecular analysis. The prim...
Eligibility Criteria
Inclusion
- Written informed consent by the caretakers and whenever possible the patient's assent.
- Confirmed diagnosis of MDS or JMML (morphology, cytogenetics)
- Myeloid leukemia of Down syndrome (patients aged \> 6 years).
- Age less than 18 years
Exclusion
- Denied informed consent and/or assent by caretakers/patient.
- Myeloid leukemia of Down syndrome (patients \< 6 years).
- Participation in another study within the last 4 weeks (except for therapy optimizing studies in cancer or bone marrow failure disorders and studies in diagnostics).
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT00662090
Start Date
January 1 2006
End Date
December 1 2024
Last Update
May 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Freiburg
Freiburg im Breisgau, Baden-Wurttemberg, Germany, 79106